Vivanza Biosciences Board Meeting on Aug 1 to Approve Q1 FY27 Results

Vivanza Biosciences Ltd has announced that its Board of Directors will convene on August 1, 2026, at 3:30 PM. The primary agenda items include the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report. The meeting will also address disclosures of interest under Section 164 of the Companies Act, 2013, and take note of declarations from Independent Directors under Section 149(7). The company has also informed that the trading window for designated persons remains closed until 48 hours after the declaration of financial results for the quarter and year ended June 30, 2026.